▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #2086 by analyst upside · 2026-09-27
SYK
Stryker Corporation
Healthcare · Market Cap $104B · P/E 28.3x
ANALYST PRICE TARGET
+35.5%
implied upside to consensus target
Current Price $272.36
Consensus Target $369.0
Bull Target $465.0
Bear Target $298.0
Analysts Covering 25
ANALYST CONSENSUS - BUY
Strong Buy
6
Buy
13
Hold
5
Sell
1
52-Week Low $267.0
52-Week High $392.55
YTD Return -21.4%
FUNDAMENTALS
Market Cap $104B
P/E Ratio (TTM) 28.3x
Forward P/E 16.3x
EPS (TTM) $9.64
PEG Ratio 1.27
Dividend Yield 1.29%
Revenue (TTM) $25.8B
Profit Margin 14.4%
52-WEEK RANGE
52-Week Low $267.0
52-Week High $392.55
Current Price $272.36
Bear Target $298.0
Bull Target $465.0
● Now $272.36 ● Target $369.0
TRADING DATA
Avg Volume 2.6M
YTD Return -21.4%
Analyst Count 25
Consensus Buy
Upside to Target +35.5%
Last Updated 2026-09-27

ANALYST SUMMARY

Stryker Corporation (SYK) is currently trading at $272.36 with a Wall Street consensus price target of $369.0, implying potential upside of 35.5% over the next 12 months. 25 analysts currently cover SYK, with a consensus rating of Buy - 76% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $465.0, while the most cautious has a target of $298.0.

SYK operates in the Healthcare sector with a market capitalisation of $104B. The stock is down 21.4% year-to-date and is currently trading near the lower end of its 52-week range of $267.0 – $392.55.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for SYK, with each firm's 90-day track record across all stocks we track. See full firm rankings →

TD Cowen - Reiterated
Hold → Hold 2026-09-22 Building track record
Canaccord Genuity - Reiterated
Buy → Buy 2026-09-18 Building track record
Citigroup - Reiterated
Buy → Buy 2026-09-10 Building track record
Wells Fargo - Reiterated
Overweight → Overweight 2026-09-09 Building track record
Wolfe Research ↓ Downgrade
Outperform → Peer Perform 2026-08-13 Building track record
Citizens - Reiterated
Market Outperform → Market Outperform 2026-08-03 Building track record
RBC Capital - Reiterated
Outperform → Outperform 2026-07-31 Building track record
JP Morgan - Reiterated
Overweight → Overweight 2026-07-31 43% win rate (7 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
57
out of 100
Coverage depth
25/30
Consensus clarity
18/30
Vote unanimity
12/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →